Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Status:
Completed
Trial end date:
2015-08-31
Target enrollment:
Participant gender:
Summary
We hypothesize that insulin glulisine is non-inferior to currently proven rapid-acting
insulin lispro when used in a basal/bolus regimen to treat hyperglycemia in patients with
gestational diabetes mellitus.
Phase:
Phase 2
Details
Lead Sponsor:
Sansum Diabetes Research Institute William Sansum Diabetes Center